Please Wait.....
Report
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032
Market Report I 2023-11-27 I 208 Pages I EMR Inc.
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032
Market Outlook
According to the report by Expert Market Research (EMR), the United States hereditary angioedema therapeutics market is projected to grow at a CAGR of 8.20% between 2024 and 2032 reaching a value of around USD 1256.28 million by 2032. Aided by the heightened awareness about the rare genetic disorder, advancements in drug development, and the push for early diagnosis, the market is expected to grow significantly by 2032.
Hereditary Angioedema is a rare, genetic disorder characterised by recurrent episodes of severe swelling (angioedema) in the skin, intestines, and airways. The swift and unpredictable onset of symptoms can often be debilitating and, in some cases, life-threatening. In the United States, the focus on HAE therapeutics has intensified in recent years, with several FDA-approved treatments entering the market.
One of the primary drivers of the United States hereditary angioedema therapeutics market growth is the heightened advocacy and awareness campaigns by organisations, patient groups, and medical professionals. These initiatives have illuminated the significance of early diagnosis and timely treatment, thus accelerating the demand for therapeutic solutions.
Parallelly, the U.S. has been at the forefront of research and development in the realm of HAE therapeutics. Leading pharmaceutical companies, buoyed by grants and favourable regulations, have been channelling efforts into creating innovative drug solutions, both prophylactic and acute. The increasing number of drug approvals and the robust pipeline of drugs in clinical trials further pose a positive impact on the United States hereditary angioedema therapeutics market outlook.
Moreover, the market's expansion has been underpinned by the growing emphasis on personalised medicine. With HAE manifesting differently across patients, there is a rising demand for treatments tailored to individual patient profiles. Consequently, biopharmaceutical firms are investing in genomics and precision medicine to design drugs that cater to specific patient subsets.
Medical advancements, however, have not been the sole driver of the United States hereditary angioedema therapeutics market demand. Technology, especially digital health platforms, has played a pivotal role in the evolution of the HAE therapeutics market. Mobile applications and telehealth services are facilitating symptom tracking, ensuring medication adherence, and fostering better patient-doctor communication, thereby enhancing the overall management of the disorder.
The United States market for hereditary angioedema therapeutics is at a significant inflection point. With the synergistic combination of medical research, technological advancements, and heightened awareness, the market is poised for substantial growth in the coming years. As more is understood about the genetic underpinnings of HAE and as drug portfolios diversify, the future looks promising for patients and stakeholders alike in the realm of HAE therapeutics.
Market Segmentation
The market can be divided based on drug type and route of administration.
Market Breakup by Drug Type
- C1-Esterase Inhibitor
- Bradykinin B2 Receptor Antagonist
- Kallikrein Inhibitor
- Others
Market Breakup by Route of Administration
- Intravenous
- Subcutaneous
- Oral
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the United States hereditary angioedema therapeutics market. Some of the major players explored in the report by Expert Market Research are as follows:
- Takeda Pharmaceutical Company Limited
- BioCryst Pharmaceuticals, Inc.
- Sanofi S.A.
- CSL Behring LLC.
- Pharming Group N.V.
- Cipla Inc.
- Ionis Pharmaceuticals Inc.
- Attune Pharmaceuticals, Inc.
- Adverum Biotechnologies, Inc
- Others
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 United States Hereditary Angioedema Therapeutics Market Analysis
8.1 Key Industry Highlight
8.2 United States Hereditary Angioedema Therapeutics Historical Market (2018-2023)
8.3 United States Hereditary Angioedema Therapeutics Market Forecast (2024-2032)
8.4 United States Hereditary Angioedema Therapeutics Market by Drug Type
8.4.1 C1-Esterase Inhibitor
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Bradykinin B2 Receptor Antagonist
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Kallikrein Inhibitor
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.4.4 Others
8.5 United States Hereditary Angioedema Therapeutics Market by Route of Administration
8.5.1 Intravenous
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Subcutaneous
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Oral
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
9 Market Dynamics
9.1 SWOT Analysis
9.1.1 Strengths
9.1.2 Weaknesses
9.1.3 Opportunities
9.1.4 Threats
9.2 Porter's Five Forces Analysis
9.2.1 Supplier's Power
9.2.2 Buyer's Power
9.2.3 Threat of New Entrants
9.2.4 Degree of Rivalry
9.2.5 Threat of Substitutes
10 Competitive Landscape
10.1 Market Structure
10.2 Company Profiles
10.2.1 Takeda Pharmaceutical Company Limited
10.2.1.1 Company Overview
10.2.1.2 Product Portfolio
10.2.1.3 Demographic Reach and Achievements
10.2.1.4 Certifications
10.2.2 BioCryst Pharmaceuticals, Inc.
10.2.2.1 Company Overview
10.2.2.2 Product Portfolio
10.2.2.3 Demographic Reach and Achievements
10.2.2.4 Certifications
10.2.3 Sanofi S.A.
10.2.3.1 Company Overview
10.2.3.2 Product Portfolio
10.2.3.3 Demographic Reach and Achievements
10.2.3.4 Certifications
10.2.4 CSL Behring LLC.
10.2.4.1 Company Overview
10.2.4.2 Product Portfolio
10.2.4.3 Demographic Reach and Achievements
10.2.4.4 Certifications
10.2.5 Pharming Group N.V.
10.2.5.1 Company Overview
10.2.5.2 Product Portfolio
10.2.5.3 Demographic Reach and Achievements
10.2.5.4 Certifications
10.2.6 Cipla Inc.
10.2.6.1 Company Overview
10.2.6.2 Product Portfolio
10.2.6.3 Demographic Reach and Achievements
10.2.6.4 Certifications
10.2.7 Ionis Pharmaceuticals Inc.
10.2.7.1 Company Overview
10.2.7.2 Product Portfolio
10.2.7.3 Demographic Reach and Achievements
10.2.7.4 Certifications
10.2.8 Attune Pharmaceuticals, Inc.
10.2.8.1 Company Overview
10.2.8.2 Product Portfolio
10.2.8.3 Demographic Reach and Achievements
10.2.8.4 Certifications
10.2.9 Adverum Biotechnologies, Inc
10.2.9.1 Company Overview
10.2.9.2 Product Portfolio
10.2.9.3 Demographic Reach and Achievements
10.2.9.4 Certifications
10.2.10 Others
11 Key Trends and Developments in the Market
List of Figures and Tables
1. United States Hereditary Angioedema Therapeutics Market: Key Industry Highlights, 2018 and 2032
2. United States Hereditary Angioedema Therapeutics Historical Market: Breakup by Drug Type (USD Million), 2018-2023
3. United States Hereditary Angioedema Therapeutics Market Forecast: Breakup by Drug Type (USD Million), 2024-2032
4. United States Hereditary Angioedema Therapeutics Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5. United States Hereditary Angioedema Therapeutics Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6. United States Hereditary Angioedema Therapeutics Market Structure
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security